Neurocrine Biosciences (NBIX) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $155.13 -0.33%
EPS Growth %: -12.4%
Financial Fact:
Income (loss) from operations: -38.44M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -12.4%
Financial Fact:
Income (loss) from operations: -38.44M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of ($0.07), $0.10 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- BMO Capital Starts Abercrombie & Fitch (anf) at Outperform
- Chime to acquire Stride Bank for $590M in cash
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
